XML Sitemap

This is a XML Sitemap which is supposed to be processed by search engines which follow the XML Sitemap standard like Ask.com, Bing, Google and Yahoo.
It was generated using the WordPress content management system and the Google Sitemap Generator Plugin by Arne Brachhold.
You can find more information about XML sitemaps on sitemaps.org and Google's list of sitemap programs.

URLPriorityChange frequencyLast modified (GMT)
http://www.dailyhealthindustry.it/pfizer-parere-positivo-chmp-per-besponsa-leucemia-linfoblastica-acuta-ID5767.html20%Monthly2017-04-28 16:52
http://www.dailyhealthindustry.it/bayer-ok-da-fda-per-stivarga-cancro-epatico-ID5765.html20%Monthly2017-04-28 16:36
http://www.dailyhealthindustry.it/biogen-ancora-leader-nella-sm-ma-aumenta-la-concorrenza-ID5763.html20%Monthly2017-04-28 16:24
http://www.dailyhealthindustry.it/biomarin-da-fda-ok-a-farmaco-per-malattia-rara-ma-il-prezzo-e-altissimo-ID5760.html20%Monthly2017-04-28 16:08
http://www.dailyhealthindustry.it/world-economic-forum-piattaforma-multistakeholder-per-valutare-farmaci-ID5757.html20%Monthly2017-04-28 16:09
http://www.dailyhealthindustry.it/daiichi-sankyo-135-mln-di-dollari-per-produrre-adc-ID5755.html20%Monthly2017-04-28 15:42
http://www.dailyhealthindustry.it/epatite-c-aifa-autorizza-rimborsabilita-epclusa-gilead-ID5751.html20%Monthly2017-04-27 17:48
http://www.dailyhealthindustry.it/gentiloni-milano-ha-ottime-chance-per-nuova-sede-ema-ID5748.html20%Monthly2017-04-27 17:11
http://www.dailyhealthindustry.it/brexit-pharma-teme-per-uk-un-tiny-market-ID5745.html20%Monthly2017-04-27 16:59
http://www.dailyhealthindustry.it/melazzini-aifa-ssn-innovativo-ed-equo-nhs-a-rischio-collasso-ID5743.html20%Monthly2017-04-27 16:16
http://www.dailyhealthindustry.it/amgen-bene-il-q1-chi-spingera-le-vendite-dopo-enbrel-ID5740.html20%Monthly2017-04-27 16:19
http://www.dailyhealthindustry.it/novartis-e-amgen-insieme-per-erenumab-emicrania-ID5738.html20%Monthly2017-04-27 15:33
http://www.dailyhealthindustry.it/portfolio-otc-per-johnson-novartis-e-takeda-e-in-brasile-ID5735.html20%Monthly2017-04-27 13:16
http://www.dailyhealthindustry.it/fresenius-si-accaparra-akorn-e-lunita-biosimilari-di-merck-kgaa-ID5728.html20%Monthly2017-04-26 15:45
http://www.dailyhealthindustry.it/malaria-oms-al-via-sperimentazione-sul-campo-primo-vaccino-approvato-ID5726.html20%Monthly2017-04-26 15:07
http://www.dailyhealthindustry.it/eli-lilly-co-dopo-crollo-novembre-azioni-si-impennato-del-22-ID5724.html20%Monthly2017-04-26 15:00
http://www.dailyhealthindustry.it/bigpharma-punta-sulla-steatoepatite-non-alcoolica-ID5722.html20%Monthly2017-04-26 15:45
http://www.dailyhealthindustry.it/sanofiregeneron-panel-ema-raccomanda-approvazione-kevzara-artrite-reumatoide-ID5720.html20%Monthly2017-04-26 15:44
http://www.dailyhealthindustry.it/uniqure-ritira-prima-terapia-genica-approvata-in-europa-ID5717.html20%Monthly2017-04-26 15:44
http://www.dailyhealthindustry.it/fondazione-gates-300-mln-di-dollari-per-sconfiggere-le-malattie-tropicali-ID5708.html20%Monthly2017-04-21 15:53
http://www.dailyhealthindustry.it/malattie-rare-ecco-la-top-five-dei-farmaci-piu-costosi-ID5705.html20%Monthly2017-04-21 16:59
http://www.dailyhealthindustry.it/fujifilm-dalle-foto-ai-farmaci-biologici-con-130-mln-di-dollari-ID5700.html20%Monthly2017-04-21 17:08
http://www.dailyhealthindustry.it/abbvie-veliparib-fallisce-due-late-stage-trial-ID5697.html20%Monthly2017-04-21 13:24
http://www.dailyhealthindustry.it/teva-sfida-gsk-nel-respiratorio-e-lancia-generico-di-advair-ID5695.html20%Monthly2017-04-21 13:11
http://www.dailyhealthindustry.it/usa-svizzera-testa-a-testa-per-un-mercato-da-800-mln-di-dollari-ID5691.html20%Monthly2017-04-21 16:12
http://www.dailyhealthindustry.it/farmindustria-aringhieri-progetto-giovani-per-avvicinare-gli-studenti-alla-ricerca-ID5684.html20%Monthly2017-04-20 17:20
http://www.dailyhealthindustry.it/credit-suisse-laumento-dei-prezzi-fa-crescere-gli-utili-ma-non-per-tutti-ID5681.html20%Monthly2017-04-20 17:51
http://www.dailyhealthindustry.it/roche-nuove-evidenze-positive-per-emicizumab-emofilia-ID5679.html20%Monthly2017-04-20 14:40
http://www.dailyhealthindustry.it/ricciardi-iss-in-italia-ce-unepidemia-di-morbillo-ID5676.html20%Monthly2017-04-20 17:36
http://www.dailyhealthindustry.it/chiesi-2016-da-incorniciare-ID5674.html20%Monthly2017-04-20 13:57
http://www.dailyhealthindustry.it/cina-un-mercato-da-300-mld-di-dollari-ID5672.html20%Monthly2017-04-20 13:42
http://www.dailyhealthindustry.it/nuovi-antibiotici-iclaprim-motif-bio-efficace-come-vancomicina-ID5667.html20%Monthly2017-04-19 14:57
http://www.dailyhealthindustry.it/merck-kgaa-entro-due-anni-formulazione-pediatrica-di-praziquantel-schistosomiasi-ID5664.html20%Monthly2017-04-19 17:34
http://www.dailyhealthindustry.it/johnson-q1-sotto-le-aspettative-ma-con-actelion-previsioni-ottimistiche-ID5661.html20%Monthly2017-04-19 14:25
http://www.dailyhealthindustry.it/shopping-cardinal-health-tre-bu-medtronic-per-ampliare-il-business-dei-dispositivi-ID5659.html20%Monthly2017-04-19 17:16
http://www.dailyhealthindustry.it/antibiotico-resistenza-i-lysibodies-sono-la-soluzione-ID5655.html20%Monthly2017-04-19 10:36
http://www.dailyhealthindustry.it/non-compliance-terapeutica-il-killer-silenzioso-degli-usa-ID5652.html20%Monthly2017-04-19 17:16
http://www.dailyhealthindustry.it/oncologia-e-nash-novartis-spinge-sullacceleratore-ID5645.html20%Monthly2017-04-18 16:10
http://www.dailyhealthindustry.it/buoni-risultati-per-emicizumab-roche-nuovo-competitor-nellemofilia-ID5641.html20%Monthly2017-04-18 16:34
http://www.dailyhealthindustry.it/lilly-incyte-fda-dice-no-a-olumian-artrite-reumatoide-ID5638.html20%Monthly2017-04-18 17:30
http://www.dailyhealthindustry.it/abbott-alere-diagnostici-e-sua-dopo-un-anno-di-trattative-e-colpi-di-scena-ID5636.html20%Monthly2017-04-18 14:47
http://www.dailyhealthindustry.it/oncomed-tarextumab-tumore-al-polmone-fallisce-studio-fase-intermedia-ID5634.html20%Monthly2017-04-18 13:16
http://www.dailyhealthindustry.it/roche-fda-estende-tecentriq-a-tumore-vescica-come-trattamento-prima-linea-ID5631.html20%Monthly2017-04-18 10:23
http://www.dailyhealthindustry.it/ema-a-milano-enzo-moavero-ambasciatore-del-governo-italiano-ID5626.html20%Monthly2017-04-14 13:28
http://www.dailyhealthindustry.it/xenotrapianti-business-del-futuro-ID5622.html20%Monthly2017-04-13 16:07
http://www.dailyhealthindustry.it/congresso-usa-accusa-istituto-ramazzini-la-replica-seguiti-gli-standard-internazionali-ID5619.html20%Monthly2017-04-14 13:58
http://www.dailyhealthindustry.it/menarini-va-alle-terme-distribuira-lacqua-di-sirmione-ID5617.html20%Monthly2017-04-13 14:48
http://www.dailyhealthindustry.it/opa-su-startup-usa-il-portfolio-fa-gola-a-takeda-e-lundbeck-ID5614.html20%Monthly2017-04-13 14:40
http://www.dailyhealthindustry.it/fondo-investimenti-usa-punta-40-mln-di-dollari-su-candidato-nash-ID5612.html20%Monthly2017-04-13 14:19
http://www.dailyhealthindustry.it/apple-irrompe-nella-bioelettronica-per-la-cura-del-diabete-ID5609.html20%Monthly2017-04-13 12:41
http://www.dailyhealthindustry.it/farmindustria-massimo-visentin-nuovo-presidente-gruppo-vaccini-ID5603.html20%Monthly2017-04-12 15:07
http://www.dailyhealthindustry.it/roche-italia-via-a-campagna-sensibilizzazione-su-sclerosi-multipla-ID5599.html20%Monthly2017-04-12 14:24
http://www.dailyhealthindustry.it/mylan-da-fda-lettera-di-richiamo-per-qualita-produzione-in-india-ID5596.html20%Monthly2017-04-12 13:04
http://www.dailyhealthindustry.it/neurocrine-fda-approva-ingrezza-discinesia-tardiva-ID5593.html20%Monthly2017-04-12 11:25
http://www.dailyhealthindustry.it/approvazione-farmaci-lfda-e-piu-veloce-dellema-ID5591.html20%Monthly2017-04-12 11:03
http://www.dailyhealthindustry.it/biotecnologia-low-cost-azienda-indiana-lancia-test-ematico-per-loncologia-ID5588.html20%Monthly2017-04-12 10:40
http://www.dailyhealthindustry.it/icer-il-prezzo-di-humira-e-alto-abbvie-verso-una-second-brand-strategy-ID5583.html20%Monthly2017-04-11 16:38
http://www.dailyhealthindustry.it/roche-nel-tumore-al-polmone-alecensa-piu-efficace-di-xalkori-pfizer-ID5581.html20%Monthly2017-04-11 15:14
http://www.dailyhealthindustry.it/merger-q1-fiacco-rispetto-al-2016-spicca-laccordo-johnson-actelion-ID5578.html20%Monthly2017-04-11 12:57
http://www.dailyhealthindustry.it/teva-per-fare-cassa-pronta-a-vendere-la-bu-della-salute-femminile-ID5576.html20%Monthly2017-04-11 11:22
http://www.dailyhealthindustry.it/sanofi-bene-toujeo-nello-studio-real-world-ID5574.html20%Monthly2017-04-11 11:11
http://www.dailyhealthindustry.it/johnson-in-dubbio-su-imetelstat-mielofibrosi-salta-lacquisizione-da-geron-ID5571.html20%Monthly2017-04-11 10:19
http://www.dailyhealthindustry.it/abbott-lancia-in-europa-proclaim-drg-per-il-dolore-cronico-ID5569.html20%Monthly2017-04-10 16:51
http://www.dailyhealthindustry.it/brevetti-litalia-riprende-a-inventare-ma-i-numeri-sono-ancora-bassi-ID5567.html20%Monthly2017-04-10 15:30
http://www.dailyhealthindustry.it/fda-warning-su-clorexidina-a-rischio-un-business-da-56-mld-di-dollari-ID5565.html20%Monthly2017-04-10 15:02
http://www.dailyhealthindustry.it/takeda-parte-sperimentazione-fase-iii-vaccino-dengue-ID5563.html20%Monthly2017-04-10 14:31
http://www.dailyhealthindustry.it/svizzera-nasce-vifor-pharma-800-mln-sul-piatto-per-gli-investimenti-ID5560.html20%Monthly2017-04-10 10:59
http://www.dailyhealthindustry.it/il-nemico-invisibile-documentario-cnn-sulle-malattie-infettive-sponsor-johnon-ID5555.html20%Monthly2017-04-10 10:39
http://www.dailyhealthindustry.it/gilead-fda-estende-sovaldi-e-harvoni-a-popolazione-pediatrica-ID5553.html20%Monthly2017-04-10 10:04
http://www.dailyhealthindustry.it/gsk-italia-tre-nasce-gsk-ID5547.html20%Monthly2017-04-07 16:39
http://www.dailyhealthindustry.it/genomica-unindustria-da-due-mld-di-dollari-con-molte-incognite-etiche-ID5544.html20%Monthly2017-04-07 16:59
http://www.dailyhealthindustry.it/valeant-per-inova-il-prezzo-non-e-giusto-ID5542.html20%Monthly2017-04-07 16:58
http://www.dailyhealthindustry.it/fda-autorizza-kit-test-genetici-per-10-patologie-ID5539.html20%Monthly2017-04-07 12:58
http://www.dailyhealthindustry.it/inovio-combo-vaccino-inibitore-di-checkpoint-per-hiv-ID5536.html20%Monthly2017-04-07 11:05
http://www.dailyhealthindustry.it/gilead-prepara-lo-sbarco-in-cina-con-ex-vp-roche-alla-guida-ID5534.html20%Monthly2017-04-07 10:42
http://www.dailyhealthindustry.it/sanofi-bill-sibold-a-capo-del-gruppo-in-usa-ID5529.html20%Monthly2017-04-06 11:52
http://www.dailyhealthindustry.it/novartis-ok-fda-a-combo-tafinlar-mekinist-tumore-del-polmone-ID5527.html20%Monthly2017-04-06 17:14
http://www.dailyhealthindustry.it/almirall-sun-pharma-tildrakizumab-sclerosi-a-placche-sul-tavolo-dellema-ID5524.html20%Monthly2017-04-06 11:37
http://www.dailyhealthindustry.it/medtronic-italia-allu-s-italy-patient-day-2017-ID5522.html20%Monthly2017-04-06 11:12
http://www.dailyhealthindustry.it/ibm-watson-a-milano-maroni-occasione-da-non-perdere-ID5519.html20%Monthly2017-04-06 11:08
http://www.dailyhealthindustry.it/antidepressivi-italia-paese-europeo-che-ne-consuma-di-meno-ma-il-mercato-cresce-ID5516.html20%Monthly2017-04-06 17:15
http://www.dailyhealthindustry.it/assobiomedica-bene-nuove-norme-europee-sui-dm-litalia-ha-fatto-squadra-ID5510.html20%Monthly2017-04-05 18:18
http://www.dailyhealthindustry.it/johnson-e-johnson-no-da-partner-per-nuovi-studi-su-darzalex-ID5507.html20%Monthly2017-04-05 16:15
http://www.dailyhealthindustry.it/astellas-acquisisce-ogeda-per-espandersi-nella-ginecologia-ID5504.html20%Monthly2017-04-05 16:00
http://www.dailyhealthindustry.it/amgen-blinatumomab-leucemia-rimborsabile-in-italia-ID5500.html20%Monthly2017-04-05 18:24
http://www.dailyhealthindustry.it/boeringher-ingheleim-53-mld-di-euro-entro-il-2030-dallanimal-health-ID5498.html20%Monthly2017-04-05 15:05
http://www.dailyhealthindustry.it/novocure-dispositivo-indossabile-optune-efficace-nel-tumore-del-pancreas-ID5495.html20%Monthly2017-04-05 14:55
http://www.dailyhealthindustry.it/teva-fd-approva-austedo-corea-di-huntington-ID5492.html20%Monthly2017-04-05 15:32
http://www.dailyhealthindustry.it/farmaci-quale-politica-di-pricing-per-i-chckpoint-inhibitors-ID5486.html20%Monthly2017-04-07 13:24
http://www.dailyhealthindustry.it/paratek-antibiotico-omadaciclina-supera-studio-fase-avanzata-ID5484.html20%Monthly2017-04-04 15:03
http://www.dailyhealthindustry.it/biogen-per-tecfidera-nessuna-violazione-brevetto-forward-pharma-ID5481.html20%Monthly2017-04-04 13:12
http://www.dailyhealthindustry.it/amgen-sanofiregeneron-duello-in-corte-dappello-usa-per-repatha-ID5479.html20%Monthly2017-04-04 11:06
http://www.dailyhealthindustry.it/cannes-lions-health-21-giudici-e-due-categorie-premiano-la-comunicazione-pharma-ID5477.html20%Monthly2017-04-04 10:55
http://www.dailyhealthindustry.it/combo-tutti-vogliono-incyte-al-via-trial-con-keytruda-msd-e-opdivo-bms-ID5474.html20%Monthly2017-04-04 10:47
http://www.dailyhealthindustry.it/aifa-ecco-i-criteri-di-rimborsabilita-per-i-daas-ID5470.html20%Monthly2017-04-03 16:15
http://www.dailyhealthindustry.it/philips-accordo-con-biotech-per-intelligenza-artificiale-nel-cancro-al-seno-ID5468.html20%Monthly2017-04-03 14:32
http://www.dailyhealthindustry.it/vencerx-malattie-neurologiche-rare-ex-pfizer-nuovo-ceo-ID5465.html20%Monthly2017-04-03 13:52
http://www.dailyhealthindustry.it/google-venture-5-mln-di-dollari-per-super-colla-batteri-ID5460.html20%Monthly2017-04-03 17:12
http://www.dailyhealthindustry.it/biotech-canadese-mette-a-punto-test-per-creme-bioequivalenti-herpes-ID5458.html20%Monthly2017-04-03 17:13
http://www.dailyhealthindustry.it/worldwide-clinical-trials-bill-hirschman-e-il-nuovo-evp-ID5455.html20%Monthly2017-04-03 11:10